MMP9 and cancer: Expression of matrix metalloproteinase (MMP9), phosphorylated STAT3, total STAT3, JAK2, IL6 and cleaved caspase proteins in MCF-7 and MDA-MB-231 cancer cells before and after treatment with the IC50 of azilsartan for 48 h is shown in Figure 8.